FindTrial
Sign In

dexamethasone in supraclavicular brachial plexus block

Bupivacaine- lidocaine versus bupivacaine- lidocaine plus dexamethasone in supraclavicular brachial plexus block - Bupivacaine- lidocaine versus bupivacaine- lidocaine plus dexamethasone in supraclavicular brachial plexus block:dexamethasone in supraclavicular brachial plexus block

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000043813
Enrollment
60
Registered
2021-06-01
Start date
2015-05-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

regional block

Interventions

received 40 mL solution containing local anesthetics only received 40 mL solution containing local anesthetics plus 4mg dexamethasone

Sponsors

Minia University, Faculty of medicine anesthesia and intensive care department
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists (ASA) physical status I, II, and III patients undergoing upper limb surgery either elective or emergent.

Exclusion criteria

Exclusion criteria: patient refusal, patients with damage or disease of the brachial plexus, any bleeding disorder, on anticoagulants, neuromuscular diseases, peripheral neuropathy, local skin infection at the site of injection, or history of allergy to any of the studied drugs

Design outcomes

Primary

MeasureTime frame
Onset time of sensory and motor block, duration of sensory and motor block—

Countries

Africa

Contacts

Public ContactAmr abdelrazik

Minya University,Faculty of medicine anesthesia and intensive care department

m.amr274@yahoo.com00201023451177

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026